Paragon Capital Management (Colorado)’s Bristol-Myers Squibb BMY Stock Holding History

Paragon Capital Management (Colorado)’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$258K	Buy	4,137 +5	+0.1%	+$316	0.05%	133
2026 Q2	$238K	Buy	4,132 +6	+0.1%	+$345	0.05%	162
2026 Q1	$250K	Sell	4,126 -3	-0.1%	-$175	0.05%	155
2025 Q4	$223K	Buy	+4,129	New	+$199K	0.04%	175
2025 Q2	–	Sell	-3,909	Closed	-$238K	–	217
2025 Q1	$238K	Hold	3,909	–	–	0.05%	162
2024 Q4	$221K	Hold	3,909	–	–	0.04%	165
2024 Q3	$202K	Buy	+3,909	New	+$183K	0.04%	199
2023 Q3	–	Sell	-3,268	Closed	-$209K	–	191
2023 Q2	$209K	Sell	3,268 -394	-11%	-$26.4K	0.05%	183
2023 Q1	$254K	Sell	3,662 -144	-4%	-$10.2K	0.06%	119
2022 Q4	$274K	Buy	3,806 +4	+0.1%	+$302	0.07%	96
2022 Q3	$270K	Buy	3,802 +323	+9%	+$23.4K	0.08%	81
2022 Q2	$268K	Buy	3,479 +5	+0.1%	+$381	0.07%	88
2022 Q1	$254K	Buy	3,474 +6	+0.2%	+$403	0.05%	118
2021 Q4	$216K	Buy	3,468 +5	+0.1%	+$293	0.03%	159
2021 Q3	$205K	Buy	3,463 +5	+0.1%	+$329	0.04%	164
2021 Q2	$231K	Buy	3,458 +5	+0.1%	+$326	0.11%	91
2021 Q1	$218K	Buy	3,453 +5	+0.1%	+$311	0.11%	94
2020 Q4	$214K	Buy	+3,448	New	+$212K	0.12%	88
2018 Q4	–	Sell	-3,950	Closed	-$245K	–	199
2018 Q3	$245K	Buy	3,950 +1	+0%	+$59	0.21%	169
2018 Q2	$219K	Buy	3,949 +737	+23%	+$39.8K	0.19%	187
2018 Q1	$203K	Buy	+3,212	New	+$207K	0.09%	206
2017 Q4	–	Sell	-3,891	Closed	-$248K	–	190
2017 Q3	$248K	Buy	+3,891	New	+$227K	0.1%	157

Other funds holding BMY

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return

Paragon Capital Management (Colorado)'s BMY Position: Q3 2026 in Review

Paragon Capital Management (Colorado) increased its Bristol-Myers Squibb (BMY) stake by 0.12% in Q3 2026, buying an estimated $316 and bringing the position to 4,137 shares worth $258K. The position accounts for 0.05% of the portfolio, ranked #133.

Paragon Capital Management (Colorado) first reported a position in BMY in Q3 2017 and has held it in 22 quarters since. The position peaked at $274K in Q4 2022. 404 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

Paragon Capital Management (Colorado) held 4,137 shares of Bristol-Myers Squibb worth $258K as of Q3 2026.
Paragon Capital Management (Colorado) bought 5 Bristol-Myers Squibb shares in Q3 2026, an estimated $316.
Bristol-Myers Squibb made up 0.05% of Paragon Capital Management (Colorado)'s portfolio in Q3 2026, its #133 holding.
Paragon Capital Management (Colorado) first reported a position in Bristol-Myers Squibb in Q3 2017 and has held it in 22 quarters since.
Paragon Capital Management (Colorado)'s Bristol-Myers Squibb position peaked at $274K in Q4 2022.
404 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Paragon Capital Management (Colorado)'s 13F filing for Q3 2026, filed 9 Oct 2026.